# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-048385
Filing Date
2023-04-21
Accepted
2023-04-21 16:08:56
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tm231857d4_defa14a.htm | DEFA14A | 12304
2 | GRAPHIC | tm231857d4_defa14aimg001.jpg | GRAPHIC | 347918
3 | GRAPHIC | tm231857d4_defa14aimg002.jpg | GRAPHIC | 234130
| Complete submission text file | 0001104659-23-048385.txt |  | 815538

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35060 | Film No.: 23836435
SIC: 2834 Pharmaceutical Preparations